Recently, the pharmaceuticals industry, which is composed of drug makers, distributors, and wholesalers, along with biotechnology firms, has been doing very well relative to other industries. Between 1992 and 2002, revenue has more than tripled among biotech firms alone, reaching nearly $30 billion. An increasingly aging population taking more and more medications promises further growth.

There are 119 members in the gE Network for this industry.